Despite Projections of a 2024 Adalimumab Biosimilar Boom, Humira Remains Dominant for Now, According to Spherix Global Insights
US gastroenterologists more in favor of biosimilars than rheumatology and dermatology counterpartsEXTON, PA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights compiled data from their ...
LionhearTV8h
Boehringer Ingelheim’s Stop Rabies program expands to drive essential vaccination and neutering initiatives in Marinduque
Boehringer Ingelheim’s Stop Rabies program expands to drive essential vaccination and neutering initiatives in Marinduque. The Stop Rabies program in the Philippines, spearheaded by Boehringer ...
Boehringer's Nerandomilast Meets Primary Endpoint In Pivotal Phase-III FIBRONEERTM-IPF Study
Boehringer Ingelheim announced today that the FIBRONEERTM-IPF trial met its primary endpoint, which was the absolute change ...
BioSpace10h
5 Schizophrenia Candidates Chasing BMS’ KarXT
As the FDA prepares to render a verdict on BMS’ closely watched schizophrenia drug, BioSpace takes a closer look at the ...
Medscape14h
Insulin Therapy De-Escalation to Fixed-Ratio Combo Safe
The study was an investigator-initiated trial supported by Sanofi. Haluzik has previously consulted and given lectures for Sanofi, Eli Lilly and Company, Novo Nordisk, AstraZeneca, Boehringer ...
dvm36023h
Paws and profits: Latest veterinary appointments in business and academia
Andrew M Hoffman, DVM, DVSc, DACVIM, will be continuing his term as the Gilbert S Kahn dean of the University of Pennsylvania ...